Comparative study between mitomycin C versus Bacillus Calmette-Guérin (BCG) in high-risk non-muscle-invasive bladder cancer (202 | AcademicGPT, tlooto

Although BCG and MMC have comparable efficacy in managing high-risk NMIBC, BCG demonstrated a higher rate of adverse reactions and decision-making should consider this balance, patient preferences, an (2023), Urologia Journal, Zaza M. | AcademicGPT, tlooto for Academic and Research